1.Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, Chimoga C, Chilukutu L, Chilufya M, Kapata N et al: Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis 2015, 15(5):544–551.
2.Mudenda V, Lucas S, Shibemba A, O’Grady J, Bates M, Kapata N, Schwank S, Mwaba P, Atun R, Hoelscher M et al: Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis 2012, 15(205):22.
3.Bates M, Mudenda V, Mwaba P, Zumla A: Deaths due to respiratory tract infections in Africa: a review of autopsy studies. Curr Opin Pulm Med 2013, 19(3):229–237.
4.Lishimpi K, Chintu C, Lucas S, Mudenda V, Kaluwaji J, Story A, Maswahu D, Bhat G, Nunn AJ, Zumla A: Necropsies in African children: consent dilemmas for parents and guardians. Arch Dis Child 2001, 84(6):463–467.
5.Ordi J, Ismail MR, Carrilho C, Romagosa C, Osman N, Machungo F, Bombí JA, Balasch J, Alonso PL, Menéndez C: Clinico-Pathological Discrepancies in the Diagnosis of Causes of Maternal Death in Sub-Saharan Africa: Retrospective Analysis. PLoS Med 2009, 6(2):e1000036.
6.Griffith DE: Nontuberculous mycobacterial lung disease. Current Opinion in Infectious Diseases 2010, 23(2):185–190.
7.Falkinham JO: Mycobacterial Aerosols and Respiratory Disease. Emerging Infectious Diseases 2003, 9(7):763–767.
8.Johnson MM, Odell JA: Nontuberculous mycobacterial pulmonary infections. Journal of Thoracic Disease 2014, 6(3):210–220.
9.Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997, 156(2 Pt 2):S1–25.
10.Michael T.Sheaff DJH: Evisceration Techniques. Post Mortem Technique Handbook 2004(Second edition):82–118.
11.McCulloch TA RG: Postmortem examination of lungs: A preservation technique for opening the bronchi and pulmonary arteries without transection problems. J Clin Pathol 1998, 51:163–164.
12.van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM et al: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31(2):406–409.
13.Huard RC, Lazzarini LC, Butler WR, van Soolingen D, Ho JL: PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol 2003, 41(4):1637–1650.
14.Springer B, Stockman L, Teschner K, Roberts GD, Bottger EC: Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 1996, 34(2):296–303.
15.Turenne CY, Tschetter L, Wolfe J, Kabani A: Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 2001, 39(10):3637–3648.
16.Maurya AK, Nag VL, Kant S, Kushwaha RAS, Kumar M, Mishra V, Rahman W, Dhole TN: Evaluation of an immunochromatographic test for discrimination between Mycobacterium tuberculosis complex & non tuberculous mycobacteria in clinical isolates from extra-pulmonary tuberculosis. Indian Journal of Medical Research 2012, 135(6):901–906.
17.Muhumuza J, Asiimwe B, Kayes S, Mugyenyi R, Whalen C, Mugerwa R, Boom H, Eisenach K, Joloba M: Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country. Int J Tuberc Lung Dis 2006, 10(11):1262 - 1267.
18.Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M et al: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. Journal of clinical microbiology 1997, 35(4):907–914.
19.Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, Driscoll J, Heersma H, Lillebaek T, Quitugua T, Rastogi N et al: Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis 2001, 5(3):216–219.
20.Demay C, Liens B, Burguière T, Hill V, Couvin D, Millet J, Mokrousov I, Sola C, Zozio T, Rastogi N: SITVITWEB—A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infection, Genetics and Evolution 2012, 12(4):755–766.
21.Bazira J, Asiimwe B, Joloba M, Bwanga F, Matee M: Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda. BMC Infectious Diseases 2011, 11(1):81.
22.Warren R, Streicher E, Sampson S, van der Spuy G, Richardson M, Nguyen D, Behr M, Victor T, van Helden P: Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol 2002, 40(12):4457 - 4465.
23.Sola C, Filliol I, Legrand E, Mokrousov I, Rastogi N: Mycobacterium tuberculosis phylogeny reconstruction based on combined numerical analysis with IS1081, IS6110, VNTR, and DR-based spoligotyping suggests the existence of two new phylogeographical clades. J Mol Evol 2001, 53(6):680–689.
24.Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M, Beaumel A, Kestens L, Kadio A: Contribution of tuberculosis to slim disease in Africa. Bmj 1994, 308(6943):1531–1533.
25.F. S. Rana MPH, C. Mwachari et al.,: “Autopsy study of HIV–1-positive and HIV–1-negative adult medical patients in Nairobi, Kenya,”. Journal of Acquired Immune Deficiency Syndromes, 2000., vol. 24,(no. 1,): pp. 23–29,.
26.Hunter RL: Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis 2011, 91(6):497–509.
27.Ogarkov O, Mokrousov I, Sinkov V, Zhdanova S, Antipina S, Savilov E: ‘Lethal’ combination of Mycobacterium tuberculosis Beijing genotype and human CD209 –336G allele in Russian male population. Infect Genet Evol 2012, 12(4):732–736.
28.Asiimwe BB, Koivula T, Kallenius G, Huard RC, Ghebremichael S, Asiimwe J, Joloba ML: Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Int J Tuberc Lung Dis 2008, 12(4):386–391.
29.Wamala D, Asiimwe B, Kigozi E, Mboowa G, Joloba M, Kallenius G: Clinico-pathological features of tuberculosis due to Mycobacterium tuberculosis Uganda genotype in patients with tuberculous lymphadenitis: a cross sectional study. BMC Clin Pathol 2014, 14(1):1472–6890.
30.Tortoli E: Clinical manifestations of nontuberculous mycobacteria infections. Clinical Microbiology and Infection 2009, 15(10):906–910.
31.Kakugawa T, Mukae H, Kajiki S, Tanaka A, Yamayoshi T, Inoue M, Ohtani H, Sakamoto N, Izumikawa K, Tasaki H et al: Mycobacterium avium Pleuritis in a Non-Immunocompromised Patient. Intern Med 2008, 47(19):1727–1731.
32.Diagnostic Standards and Classification of Tuberculosis in Adults and Children. American Journal of Respiratory and Critical Care Medicine 2000, 161(4):1376–1395.
33.Chan ED, Iseman MD: Underlying host risk factors for nontuberculous mycobacterial lung disease. Semin Respir Crit Care Med 2013, 34(1):110–123.
34.O’Brien RJ, Geiter LJ, Snider DE, Jr.: The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987, 135(5):1007–1014.
35.Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Koksalan K et al: Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004, 8(10):1186–1193.
36.Henry MT, Inamdar L, O’Riordain D, Schweiger M, Watson JP: Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004, 23(5):741–746.
37.Boggs DS: The changing spectrum of pulmonary infections due to nontuberculous mycobacteria. J Okla State Med Assoc 1995, 88(9):373–382.
38.Katalinic-Jankovic V, Grle SP, Obrovac M, Cvetnic E, Alfirevic T: [Infections due to nontuberculous mycobacteria]. Lijec Vjesn 2007, 129(5):146–151.
39.von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W et al: Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. Int J Tuberc Lung Dis 2011, 15(8):1087–1092.
40.Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF et al: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175(4):367–416.
41.Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581–620.
42.Dorman SE, Holland SM: Interferon-gamma and interleukin–12 pathway defects and human disease. Cytokine Growth Factor Rev 2000, 11(4):321–333.
43.Yates MD, Pozniak A, Grange JM: Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984–92. Thorax 1993, 48(10):990–995.
44.Miguez-Burbano MJ, Flores M, Ashkin D, Rodriguez A, Granada AM, Quintero N, Pitchenik A: Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected subjects. International Journal of Infectious Diseases 2006, 10(1):47–55.
45.Iseman MD, Marras TK: The Importance of Nontuberculous Mycobacterial Lung Disease. American Journal of Respiratory and Critical Care Medicine 2008, 178(10):999–1000.
46.Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S: Disseminated Nontuberculous Mycobacterial Infection in Patients Who Are Not Infected with HIV in Thailand. Clinical Infectious Diseases 2007, 45(4):421–427.